# A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

> **NCT03439436** · PHASE3 · COMPLETED · sponsor: **McNeil AB** · enrollment: 140 (actual)

## Conditions studied

- Nasal Congestion

## Interventions

- **DRUG:** xylo+dex nasal spray (0.1 mg+5 mg/dose)
- **DRUG:** Nasic

## Key facts

- **NCT ID:** NCT03439436
- **Lead sponsor:** McNeil AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-26
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03439436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03439436, "A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03439436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*